ARR nearly doubled to $70 million; iCBT service launched following
acquisition of e-Hub Health
MONTREAL, Aug. 11, 2021 /CNW Telbec/ - Dialogue Health
Technologies Inc. (TSX: CARE) ("Dialogue" or the "Company"),
Canada's premier health and
wellness virtual healthcare platform, announced today its financial
and operational results for the three and six months ended
June 30, 2021. Financial references
are in Canadian dollars unless otherwise indicated.
"We expanded our member base by 91% year-over-year and our
annual recurring and reoccurring revenue by 96%, driven by
significant and sustained organic growth in concert with our
ongoing successful acquisition activity," said Cherif Habib, CEO of
Dialogue. "We also strengthened our Integrated Health Platform™
offering through the acquisition of iCBT leader e-Hub Health Pty
Ltd. and the subsequent launch of Dialogue's iCBT program. As we
move into the second half of the year, we are well positioned to
maintain a strong momentum through our partnerships, technologies,
and multidisciplinary approach to care."
Q2 2021 Financial Highlights
(All capitalized terms not defined herein, shall have the
meaning ascribed to them in the Management's Discussion and
Analysis for the three and six months ended June 30, 2021; Comparison periods in each case
are the three months ended June 30,
2020, unless otherwise stated)
- Annual Recurring and Reoccurring Revenue grew 96.1% year over
year to $70.0 million driven by new
customer wins, which include a global financial services provider,
an international law firm, and a large distributor of electrical
material, as well as program expansions and the addition of new
services by existing customers.
- Revenue increased 53.0% year-over year to $16.7 million, due to growth in Members, both
Direct and from agreements with strategic distribution partners, an
increase in attach rate, as well as the acquisition of Optima
Global Health Inc. ("Optima") on October 1,
2020.
- Members grew to nearly 1.5 million, an increase of
approximately 690,000 year-over-year, or 90.5%, and approximately
185,000, or 14.6%, compared to the first quarter of 2021.
- Attach Rate grew to 1.10, compared to 1.08 at the end of the
first quarter of 2021, and 1.04 in the same period last year, as
both existing and new customers continue to leverage the multiple
services that are offered on Dialogue's Integrated Health Platform™
("IHP").
- 44% of new customers signed up for two services or more in the
second quarter of 2021. Combined with current customer expansions,
the cumulative number of customers with two or more services is now
19% compared to 16% in the first quarter of 2021 and 10% at the
same time last year.
- Net Retention Rate increased to 103% at the end of the second
quarter of 2021 from 102% as at March 31,
2021, and 101% as at December 31,
2020.
- Gross Margin declined to 41.5%, as compared to 51.2% in the
second quarter of 2020, due to the lower margin profile of the
Optima acquisition, and was stable compared to the first quarter of
2021.
- Adjusted EBITDA1 loss was $5.6 million, compared to a loss of $2.2 million in the same period last year. The
loss was due mainly to higher operating expenses to support our
growth, the launch and promotion of new services, and the
development of our technology platform, partially offset by higher
gross profit.
- Total Comprehensive Loss was $6.4
million, as compared to $3.2
million in the same period last year, due mainly to higher
operating expenses, partially offset by higher gross profit.
- Cash and Cash Equivalents were $117.0
million as of June 30, 2021
compared to $42.1 million as of
December 31, 2020. The increase was
the result of net proceeds from the initial public offering of
$90.6 million, offset in part by cash
used in operations during the first half of 2021.
Q2 2021 Business Highlights
- We acquired e-Hub Health Pty Ltd., a leading internet-based
cognitive behavioural therapy ("iCBT") provider, with products that
are amongst the most clinically validated globally. Subsequent to
quarter end, we incorporated these products into our IHP. We now
offer our clients a wider range of mental health tools with both
self-led or practitioner-led therapy.
- We successfully integrated the conversational technology we
acquired from Botfront in Q1. This technology has enabled a more
efficient design and deployment process for a wide range of current
and future conversational experiences.
- We launched a more refined and intuitive triage experience to
quickly gather our members' information and connect them to a
practitioner in minutes.
- We simplified visits for returning members by organizing all
medical summaries in an easily-accessible place - one of the most
user-requested features.
- We consolidated our iOS and Android mobile platforms on one
codebase technology to deliver new and upcoming features to all
users at a faster rate.
- We improved calendar integration functionality, launched
pre-appointment notifications, and provided members with simpler
ways to move or cancel appointments. These efforts reduced
appointment no-shows by 70%.
- We released a set of online instruction tools within our
Occupational Health and Safety ("OHS") service, providing a more
systematic and fail-proof way for our clients to implement health
and safety requirements for their operations.
- We received the Great Place to Work Certification™ for a second
consecutive year. This employee-validated recognition positions
Dialogue well to get noticed as an employer of choice and attract
great talent.
- We added Tim Hodgson to the
Board of Directors. Mr. Hodgson currently serves as board chair of
both Hydro One and Sagicor Financial Corporation Limited. Hodgson
also serves on the board of PSP Investments and was the CEO of
Goldman Sachs Canada from 2005 to 2010.
Upcoming events
- Canaccord Genuity 41st Annual Growth Conference on August 12, 2021.
- CIBC 20th Annual Eastern Institutional Investor Conference on
September 22, 2021.
- Humanizing Healthcare: The Employee Wellness Conference on
September 29-30, 2021: For the second
consecutive year, Dialogue will host a virtual event over two days,
in English and French respectively, to discuss top-of-mind health
and wellness topics for Canadian business and HR leaders. This
year's edition will feature renowned speakers, industry experts,
and exclusive sneak peeks into health benefits trends.
Notice of Conference Call
Dialogue will host a live video webinar Wednesday,
August 11, 2021 at 9:00 a.m. ET
to discuss its financial results. Cherif Habib, CEO, and
Navaid Mansuri, CFO, will co-chair
the call. All interested parties can join the event at the
following link, which is also available in the Events and
Presentations section of the Company's website. The presentation
will be accompanied by slides, which will be available on the
screen view and will be made available following the webinar
on the Company's website. Please connect at least 15 minutes
prior to the event to ensure adequate time for any software
download of Zoom that may be required to attend the event.
Listeners that prefer to dial in by phone may do so by accessing
the same web link and the dial in details will be provided by email
upon registration.
Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures,
such as "EBITDA" (which stands for net profit or loss before net
financing expenses, income taxes, depreciation of property and
equipment, amortization of intangible assets and amortization of
right-of-use assets) and "Adjusted EBITDA" (which stands for
adjusted net profit or loss before net financing expenses, income
taxes, depreciation of property and equipment, amortization of
intangible assets, amortization of right-of-use assets, transaction
costs, acquisition costs, change in fair value of conversion
feature, share-based payments expense and foreign exchange gain or
loss). These measures are not recognized under IFRS and do not have
a standardized meaning prescribed by IFRS and are therefore
unlikely to be comparable to similar measures presented by other
companies. Rather, these measures are provided as additional
information to complement those IFRS measures by providing further
understanding of our results of operations from management's
perspective. Accordingly, these measures should not be considered
in isolation nor as a substitute for analysis of our financial
information as reported under IFRS. Management also believes that
other users, such as securities analysts, investors and other
interested parties, frequently use non-IFRS measures, particularly
in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, to prepare
annual operating budgets and forecasts and to determine components
of management compensation. Where applicable, we provide a clear
quantitative reconciliation from the non-IFRS financial measures to
the most directly comparable measure calculated in accordance with
IFRS.
The following table reconciles net loss to Adjusted EBITDA loss
for the three and six months ended June 30,
2021 and 2020:
DIALOGUE HEALTH TECHNOLOGIES
INC.
ADJUSTED EBITDA
FOR THE THREE AND SIX
MONTHS ENDED JUNE 30, 2021 and
2020
(in thousands of
CAD)
|
Three months
ended
June
30,
|
|
Six months
ended
June
30,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|
|
|
|
|
|
Net loss
|
(6,668)
|
|
(3,131)
|
|
(237,906)
|
|
(8,069)
|
Net financing
expenses
|
(126)
|
|
211
|
|
62
|
|
266
|
Income
taxes
|
(50)
|
|
—
|
|
(154)
|
|
—
|
EBIT
|
(6,843)
|
|
(2,920)
|
|
(237,998)
|
|
(7,803)
|
Depreciation of
property and equipment
|
157
|
|
247
|
|
266
|
|
355
|
Amortization of
intangible assets
|
374
|
|
108
|
|
704
|
|
184
|
Amortization of
right-of-use assets
|
150
|
|
125
|
|
298
|
|
245
|
EBITDA
|
(6,162)
|
|
(2,440)
|
|
(236,730)
|
|
(7,019)
|
Share-based payments
expense
|
290
|
|
73
|
|
387
|
|
146
|
Acquisition
costs
|
137
|
|
240
|
|
180
|
|
240
|
Change in fair value
of conversion feature
|
—
|
|
(105)
|
|
225,417
|
|
(172)
|
Foreign exchange
loss (gain)
|
87
|
|
—
|
|
87
|
|
—
|
Adjusted
EBITDA
|
(5,648)
|
|
(2,232)
|
|
(10,659)
|
|
(6,804)
|
About Dialogue
Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and
wellness platform, providing affordable, on-demand access to
quality care. Through our team of health professionals, we serve
employers and organizations who have an interest in the health and
well-being of their employees, members and their families. Our
Integrated Health Platform™ is a one-stop healthcare hub that
centralizes all of our programs in a single, user-friendly
application, providing access to services 24 hours per day, 365
days per year from the convenience of a smartphone, computer or
tablet.
Forward-Looking Information
This release includes "forward-looking information" and
"forward-looking statements" (collectively, "forward-looking
statements") within the meaning of applicable securities laws.
Forward-looking information may relate to our financial outlook
(including revenues and Adjusted EBITDA), and anticipated events or
results and may include information regarding our financial
position, business strategy, growth strategies, addressable
markets, budgets, operations, financial results, taxes, dividend
policy, plans and objectives.
In some cases, but not necessarily in all cases, forward-looking
statements can be identified by the use of forward-looking
terminology such as "plans" "targets", "expects" or "does not
expect", "is expected", "an opportunity exists", "is positioned",
"estimates", "intends", "assumes", "anticipates" or "does not
anticipate" or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might", "will" or "will be taken", "occur" or "be
achieved". In addition, any statements that refer to expectations,
projections or other characterizations of future events or
circumstances contain forward-looking statements. Forward-looking
statements are not historical facts, nor guarantees or assurances
of future performance but instead represent management's current
beliefs, expectations, estimates and projections regarding future
events and operating performance.
Forward-looking statements are necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by Dialogue as of the date of this release, are subject
to inherent uncertainties, risks and changes in circumstances that
may differ materially from those contemplated by the
forward-looking statements. Important factors that could cause
actual results to differ, possibly materially, from those indicated
by the forward-looking statements include, but are not limited to,
the risk factors identified under "Risk Factors" in the Company's
latest annual information form, and in other periodic filings that
the Company has made and may make in the future with the securities
commissions or similar regulatory authorities in Canada, all of which are available under the
Company's SEDAR profile at www.sedar.com. These factors are not
intended to represent a complete list of the factors that could
affect Dialogue. However, such risk factors should be considered
carefully. There can be no assurance that such estimates and
assumptions will prove to be correct. You should not place undue
reliance on forward-looking statements, which speak only as of the
date of this release. Dialogue undertakes no obligation to publicly
update any forward-looking statement, except as required by
applicable securities laws.
Although we have attempted to identify important risk factors
that could cause actual results to differ materially from those
contained in forward-looking information, there may be other risk
factors not currently known to us or that we currently believe are
not material that could also cause actual results or future events
to differ materially from those expressed in such forward-looking
information. There can be no assurance that such information will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such information.
Accordingly, you should not place undue reliance on forward-looking
information. The forward-looking information represents our
expectations as of the date of this earnings release (or as the
date it is otherwise stated to be made) and is subject to change
after such date. However, we disclaim any intention or obligation
or undertaking to update or revise any forward-looking information
whether as a result of new information, future events or otherwise,
except as required under applicable Canadian securities laws. All
of the forward-looking information contained in this earnings
release is expressly qualified by the foregoing cautionary
statements.
DIALOGUE HEALTH TECHNOLOGIES INC.
INTERIM CONDENSED CONSOLIDATED STATEMENT OF NET LOSS AND OTHER
COMPREHENSIVE INCOME
FOR THE THREE AND SIX MONTHS ENDED JUNE 30,
2021 AND 2020
|
Three months
ended
June
30,
|
|
Six months
ended
June
30,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
|
|
|
|
|
|
Revenue
|
16,659,609
|
|
10,886,091
|
|
31,898,026
|
|
14,504,452
|
Cost of
services
|
9,750,734
|
|
5,316,828
|
|
18,658,673
|
|
7,352,796
|
Gross
profit
|
6,908,875
|
|
5,569,263
|
|
13,239,353
|
|
7,151,656
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
General and
administrative
|
8,249,119
|
|
4,788,443
|
|
15,832,795
|
|
8,224,915
|
Sales and
marketing
|
2,998,263
|
|
2,321,961
|
|
5,396,534
|
|
4,195,198
|
Product and
development
|
2,215,778
|
|
1,411,160
|
|
4,203,141
|
|
2,560,486
|
Share-based payments
expense
|
290,142
|
|
73,199
|
|
386,843
|
|
146,398
|
|
13,753,302
|
|
8,594,763
|
|
25,819,313
|
|
15,126,997
|
|
|
|
|
|
|
|
|
Operating
loss
|
(6,844,427)
|
|
(3,025,500)
|
|
(12,579,960)
|
|
(7,975,341)
|
|
|
|
|
|
|
|
|
Other
expenses
|
|
|
|
|
|
|
|
Change in fair value
of conversion feature
|
—
|
|
(105,000)
|
|
225,416,590
|
|
(171,916)
|
Net financing
expenses
|
(125,556)
|
|
211,000
|
|
62,082
|
|
265,679
|
|
(125,556)
|
|
106,000
|
|
225,478,672
|
|
93,763
|
Net loss before
income taxes
|
(6,718,871)
|
|
(3,131,500)
|
|
(238,058,632)
|
|
(8,069,104)
|
Deferred income tax
recovery
|
49,506
|
|
—
|
|
154,145
|
|
—
|
|
|
|
|
|
|
|
|
Net
loss
|
(6,669,365)
|
|
(3,131,500)
|
|
(237,904,487)
|
|
(8,069,104)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that may be
reclassified subsequently to net loss
|
|
|
|
|
|
|
Foreign currency
translation gain (loss)
|
318,309
|
(93,870)
|
|
628,843
|
|
(187,740)
|
|
|
|
|
|
|
|
|
Total
comprehensive loss
|
(6,351,056)
|
|
(3,225,370)
|
|
(237,275,644)
|
|
(8,256,844)
|
|
|
|
|
|
|
|
|
Loss per share -
basic and diluted
|
(0.10)
|
|
(0.27)
|
|
(5.12)
|
|
(0.71)
|
DIALOGUE HEALTH TECHNOLOGIES INC.
INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT JUNE 30, 2021 AND DECEMBER 31, 2020
|
June
30,
|
|
December
31,
|
|
2021
|
|
2020
|
|
$
|
|
$
|
Assets
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
117,025,986
|
|
42,067,100
|
Trade and other
receivables
|
13,086,973
|
|
11,358,615
|
Asset held for
sale
|
—
|
|
909,541
|
Prepaid
expenses
|
3,123,574
|
|
745,673
|
|
133,236,533
|
|
55,080,929
|
|
|
|
|
Property and
equipment
|
1,102,994
|
|
1,019,406
|
Right-of-use
assets
|
1,876,373
|
|
1,687,434
|
Intangible
assets
|
7,173,462
|
|
5,472,196
|
Goodwill
|
7,318,538
|
|
3,114,927
|
|
150,707,900
|
|
66,374,892
|
Liabilities
|
|
|
|
Current
liabilities
|
|
|
|
Trade payable and
accrued liabilities
|
9,614,387
|
|
7,489,083
|
Unearned
revenue
|
713,283
|
|
476,619
|
Liability related to
asset held for sale
|
—
|
|
430,110
|
Current portion of
contingent consideration payable
|
2,921,440
|
|
1,379,501
|
Current portion of
long-term debt
|
400,020
|
|
398,020
|
Current portion of
lease liabilities
|
677,263
|
|
524,618
|
|
14,326,393
|
|
10,697,951
|
|
|
|
|
Non-current portion
of lease liabilities
|
1,084,299
|
|
1,086,720
|
Non-current portion
of long-term debt
|
1,257,807
|
|
1,459,407
|
Non-current portion
of contingent consideration payable
|
1,553,002
|
|
523,499
|
Redeemable Class B
preferred shares
|
—
|
|
976,890
|
Deferred income tax
liability
|
1,019,998
|
|
82,805,661
|
Conversion option on
redeemable Class B preferred shares
|
—
|
|
92,755
|
|
19,241,499
|
|
97,642,883
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
Shareholders'
equity (deficit)
|
|
|
|
Share
capital
|
458,615,007
|
|
18,890,120
|
Equity
reserve
|
1,100,222
|
|
815,073
|
Cumulative
translation adjustment
|
223,680
|
|
(405,163)
|
Deficit
|
(328,472,508)
|
|
(50,568,021)
|
|
131,466,401
|
|
(31,267,991)
|
|
150,707,900
|
|
66,374,892
|
DIALOGUE HEALTH TECHNOLOGIES INC.
INTERIM CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30,
2021 AND 2020
|
Six months
ended
June
30,
|
|
2021
|
|
2020
|
|
$
|
|
$
|
Operating
activities
|
|
|
|
Net loss
|
(237,904,487)
|
|
(8,069,104)
|
Items not affecting
cash
|
|
|
|
Decrease on contingent
consideration
|
(358,000)
|
|
—
|
Write-off of leasehold
improvements
|
—
|
|
157,715
|
Income tax
recovery
|
(154,145)
|
|
—
|
Change in conversion
feature on preferred shares
|
225,416,590
|
|
—
|
Depreciation of
property and equipment
|
266,083
|
|
355,459
|
Amortization of
right-of-use assets
|
298,160
|
|
245,191
|
Net financing
expenses
|
62,082
|
|
265,679
|
Amortization of
intangible assets
|
703,926
|
|
183,876
|
Share-based
payments
|
386,843
|
|
146,398
|
|
(11,282,948)
|
|
(6,714,786)
|
Net changes in
non-cash operating working capital items
|
|
|
|
Trade and other
receivables
|
(1,728,358)
|
|
(5,011,472)
|
Prepaid
expenses
|
(2,377,901)
|
|
88,423
|
Trade and other
payables
|
2,125,304
|
|
3,668,712
|
Unearned
revenue
|
236,664
|
|
25,179
|
Interest
paid
|
(61,506)
|
|
(32,307)
|
Interest
income
|
249,935
|
|
—
|
|
(12,838,810)
|
|
(7,976,251)
|
|
|
|
|
Investing
activities
|
|
|
|
Purchase of property
and equipment
|
(359,685)
|
|
(170,703)
|
Purchase of intangible
assets
|
(32,190)
|
|
(62,165)
|
Sale of asset held for
sale
|
909,541
|
|
—
|
Acquisition of
Optima
|
—
|
|
—
|
Acquisition of
Botfront
|
(291,800)
|
|
—
|
Acquisition of e-Hub
Health Pty Ltd. net of cash acquired
|
(3,137,531)
|
|
—
|
|
(2,911,665)
|
|
(232,868)
|
|
|
|
|
Financing
activities
|
|
|
|
Issuance of
shares
|
100,008,000
|
|
43,235,247
|
Share issue
costs
|
(9,371,189)
|
|
—
|
Options
exercised
|
480,220
|
|
—
|
Repayment of liability
related to asset held for sale
|
(430,110)
|
|
—
|
Repayment of long-term
debt
|
(200,010)
|
|
—
|
Repayment of lease
liabilities
|
(406,393)
|
|
(287,370)
|
Transaction
costs
|
—
|
|
(500,000)
|
|
90,080,518
|
|
42,947,877
|
Effect of foreign
currency translation
|
628,843
|
|
(187,740)
|
Net increase in cash
and cash equivalents
|
74,958,886
|
|
34,551,018
|
Cash and cash
equivalents, beginning of the period
|
42,067,100
|
|
24,611,895
|
Cash and cash
equivalents, end of the period
|
117,025,986
|
|
59,162,913
|
SOURCE Dialogue Health Technologies Inc.